Mock James M
SEC CIK 1736359 · EDGAR
BoughtSold
Most active insiders at MRNA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bancel Stephane | CEO, Dir | — | $28.72M |
| 2 | Hoge Stephen | Pres | — | $28.43M |
| 3 | Mock James M | CFO | — | $4.69M |
| 4 | Klinger Shannon Thyme | CLO | — | $1.39M |
| 5 | AFEYAN NOUBAR | Dir | — | $1.14M |
| 6 | Hussain Abbas | Dir | — | $278.9K |
| 7 | Horning Sandra | Dir | — | — |
| 8 | NABEL ELIZABETH G | Dir | — | — |
| 9 | Rubenstein David M. | Dir | — | — |
| 10 | Nader Francois | Dir | — | — |
Transactions 74
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-14 16:25 | 2026-09-10 | MRNA | Moderna | Mock James M | CFO | M - OptEx | $30.96 | +19.8K | 94.2K | +27% | +$614.1K |
| DMT | 2026-09-14 16:25 | 2026-09-10 | MRNA | Moderna | Mock James M | CFO | S - Sale+OE | $134.49 | -34.8K | 59.4K | -37% | -$4.69M |
| D | 2026-09-08 17:02 | 2026-09-04 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +11.8K | 80.1K | +17% | — |
| D | 2026-09-08 17:02 | 2026-09-04 | MRNA | Moderna | Mock James M | CFO | F - Tax | $148.87 | -5,704 | 74.4K | -7% | -$849.2K |
| D | 2026-09-03 16:52 | 2026-09-01 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +2,475 | 69.5K | +4% | — |
| D | 2026-09-03 16:52 | 2026-09-01 | MRNA | Moderna | Mock James M | CFO | F - Tax | $140.34 | -1,197 | 68.3K | -2% | -$168.0K |
| DM | 2026-08-31 16:34 | 2026-08-27+ | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,103 | 67.2K | +2% | — |
| DM | 2026-08-31 16:34 | 2026-08-27+ | MRNA | Moderna | Mock James M | CFO | F - Tax | $147.60 | -535 | 67.0K | -0.8% | -$79.0K |
| D | 2026-07-06 16:30 | 2026-07-02 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,452 | 67.1K | +2% | — |
| D | 2026-07-06 16:30 | 2026-07-02 | MRNA | Moderna | Mock James M | CFO | F - Tax | $72.50 | -703 | 66.4K | -1% | -$51.0K |
| D | 2026-06-08 16:30 | 2026-06-05 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +11.8K | 71.4K | +20% | — |
| D | 2026-06-08 16:30 | 2026-06-05 | MRNA | Moderna | Mock James M | CFO | F - Tax | $51.59 | -5,705 | 65.7K | -8% | -$294.3K |
| D | 2026-06-03 16:21 | 2026-06-01 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +2,475 | 60.8K | +4% | — |
| D | 2026-06-03 16:21 | 2026-06-01 | MRNA | Moderna | Mock James M | CFO | F - Tax | $47.19 | -1,197 | 59.6K | -2% | -$56.5K |
| DM | 2026-05-29 17:13 | 2026-05-27+ | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,101 | 58.5K | +2% | — |
| DM | 2026-05-29 17:13 | 2026-05-27+ | MRNA | Moderna | Mock James M | CFO | F - Tax | $47.20 | -533 | 58.3K | -0.9% | -$25.2K |
| D | 2026-04-06 16:45 | 2026-04-02 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,453 | 58.5K | +3% | — |
| D | 2026-04-06 16:45 | 2026-04-02 | MRNA | Moderna | Mock James M | CFO | F - Tax | $50.03 | -703 | 57.7K | -1% | -$35.2K |
| D | 2026-03-06 | 2026-03-05 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +11.8K | 62.7K | +23% | — |
| D | 2026-03-06 | 2026-03-05 | MRNA | Moderna | Mock James M | CFO | F - Tax | $57.80 | -5,704 | 57.0K | -9% | -$329.7K |
| DM | 2026-03-03 | 2026-02-27 | MRNA | Moderna | Mock James M | CFO | F - Tax | $51.71 | -5,323 | 50.9K | -9% | -$275.3K |
| DM | 2026-03-03 | 2026-02-27 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +11.0K | 46.2K | +31% | — |
| 2026-02-13 | 2026-02-11 | MRNA | Moderna | Mock James M | CFO | F - Tax | $41.99 | -1,278 | 45.2K | -3% | -$53.7K | |
| 2026-02-13 | 2026-02-11 | MRNA | Moderna | Mock James M | CFO | A - Grant | $0.00 | +2,630 | 46.5K | +6% | $0 | |
| D | 2026-01-06 | 2026-01-05 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,452 | 44.7K | +3% | — |
| D | 2026-01-06 | 2026-01-05 | MRNA | Moderna | Mock James M | CFO | F - Tax | $30.86 | -780 | 43.9K | -2% | -$24.1K |
| D | 2025-12-08 | 2025-12-05 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +47.2K | 66.0K | +251% | — |
| D | 2025-12-08 | 2025-12-05 | MRNA | Moderna | Mock James M | CFO | F - Tax | $25.49 | -22.8K | 43.2K | -35% | -$581.6K |
| DM | 2025-12-01 | 2025-11-26+ | MRNA | Moderna | Mock James M | CFO | F - Tax | $24.83 | -534 | 18.7K | -3% | -$13.3K |
| DM | 2025-12-01 | 2025-11-26+ | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,102 | 19.0K | +6% | — |
| D | 2025-10-06 | 2025-10-03 | MRNA | Moderna | Mock James M | CFO | F - Tax | $28.37 | -703 | 18.3K | -4% | -$19.9K |
| D | 2025-10-06 | 2025-10-03 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,453 | 19.0K | +8% | — |
| DM | 2025-08-29 | 2025-08-27+ | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,103 | 17.7K | +7% | — |
| DM | 2025-08-29 | 2025-08-27+ | MRNA | Moderna | Mock James M | CFO | F - Tax | $24.84 | -535 | 17.5K | -3% | -$13.3K |
| D | 2025-07-07 | 2025-07-03 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,453 | 17.6K | +9% | — |
| D | 2025-07-07 | 2025-07-03 | MRNA | Moderna | Mock James M | CFO | F - Tax | $30.28 | -703 | 16.9K | -4% | -$21.3K |
| DM | 2025-05-29 | 2025-05-27+ | MRNA | Moderna | Mock James M | CFO | F - Tax | $26.41 | -533 | 16.2K | -3% | -$14.1K |
| DM | 2025-05-29 | 2025-05-27+ | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,101 | 16.4K | +7% | — |
| D | 2025-04-07 | 2025-04-04 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,452 | 16.3K | +10% | — |
| D | 2025-04-07 | 2025-04-04 | MRNA | Moderna | Mock James M | CFO | F - Tax | $25.73 | -703 | 15.6K | -4% | -$18.1K |
| D | 2025-03-03 | 2025-02-28 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +329 | 15.0K | +2% | — |
| D | 2025-03-03 | 2025-02-28 | MRNA | Moderna | Mock James M | CFO | F - Tax | $31.09 | -160 | 14.9K | -1% | -$4,974 |
| DM | 2025-02-28 | 2025-02-27 | MRNA | Moderna | Mock James M | CFO | F - Tax | $33.58 | -2,780 | 12.4K | -18% | -$93.4K |
| DM | 2025-02-28 | 2025-02-27 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +5,746 | 13.1K | +79% | — |
| D | 2025-01-06 | 2025-01-03 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,453 | 12.5K | +13% | — |
| D | 2025-01-06 | 2025-01-03 | MRNA | Moderna | Mock James M | CFO | F - Tax | $42.00 | -780 | 11.7K | -6% | -$32.8K |
| DM | 2024-12-02 | 2024-11-27 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +2,981 | 12.5K | +31% | — |
| D | 2024-12-02 | 2024-11-29 | MRNA | Moderna | Mock James M | CFO | S - Sale+OE | $42.79 | -1,420 | 11.1K | -11% | -$60.8K |
| D | 2024-10-08 | 2024-10-07 | MRNA | Moderna | Mock James M | CFO | S - Sale+OE | $60.12 | -715 | 9,505 | -7% | -$43.0K |
| D | 2024-10-08 | 2024-10-04 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,453 | 10.2K | +17% | — |
| D | 2024-08-30 | 2024-08-29 | MRNA | Moderna | Mock James M | CFO | S - Sale+OE | $78.03 | -162 | 8,767 | -2% | -$12.6K |
| D | 2024-08-30 | 2024-08-28 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +329 | 8,929 | +4% | — |
| DM | 2024-08-29 | 2024-08-27 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +2,652 | 9,921 | +36% | — |
| D | 2024-08-29 | 2024-08-28 | MRNA | Moderna | Mock James M | CFO | S - Sale+OE | $79.39 | -1,321 | 8,600 | -13% | -$104.9K |
| D | 2024-07-09 | 2024-07-08 | MRNA | Moderna | Mock James M | CFO | S - Sale+OE | $118.24 | -689 | 7,269 | -9% | -$81.5K |
| D | 2024-07-09 | 2024-07-05 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,452 | 7,958 | +22% | — |
| D | 2024-06-04 | 2024-05-31 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,326 | 7,197 | +23% | — |
| D | 2024-06-04 | 2024-06-03 | MRNA | Moderna | Mock James M | CFO | S - Sale+OE | $140.72 | -691 | 6,506 | -10% | -$97.2K |
| D | 2024-05-30 | 2024-05-28 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +328 | 6,054 | +6% | — |
| D | 2024-05-30 | 2024-05-29 | MRNA | Moderna | Mock James M | CFO | S - Sale+OE | $144.50 | -183 | 5,871 | -3% | -$26.4K |
| D | 2024-05-29 | 2024-05-28 | MRNA | Moderna | Mock James M | CFO | S - Sale+OE | $162.47 | -648 | 5,726 | -10% | -$105.3K |
| D | 2024-05-29 | 2024-05-24 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,326 | 6,374 | +26% | — |
| D | 2024-04-09 | 2024-04-05 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,453 | 5,753 | +34% | — |
| D | 2024-04-09 | 2024-04-08 | MRNA | Moderna | Mock James M | CFO | S - Sale+OE | $101.93 | -705 | 5,048 | -12% | -$71.9K |
| D | 2024-03-01 | 2024-02-29 | MRNA | Moderna | Mock James M | CFO | S - Sale+OE | $94.57 | -647 | 4,300 | -13% | -$61.2K |
| D | 2024-03-01 | 2024-02-28 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,315 | 4,947 | +36% | — |
| D | 2024-01-09 | 2024-01-05 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +1,452 | 4,404 | +49% | — |
| D | 2024-01-09 | 2024-01-08 | MRNA | Moderna | Mock James M | CFO | S - Sale+OE | $109.75 | -772 | 3,632 | -18% | -$84.7K |
| D | 2023-10-10 | 2023-10-05 | MRNA | Moderna | Mock James M | CFO | M - OptEx | — | +5,810 | 5,810 | New | — |
| D | 2023-10-10 | 2023-10-06 | MRNA | Moderna | Mock James M | CFO | S - Sale+OE | $102.50 | -2,858 | 2,952 | -49% | -$292.9K |
| M | 2022-06-27 | 2022-06-24 | RVTY | Revvity | Mock James M | Please See Remarks | S - Sale | $145.49 | -5,025 | 28.2K | -15% | -$731.1K |
| DM | 2022-02-08 | 2022-02-04+ | RVTY | Revvity | Mock James M | Please See Remarks | A - Grant | $0.00 | +15.8K | 39.0K | +68% | $0 |
| DM | 2022-02-08 | 2022-02-07 | RVTY | Revvity | Mock James M | Please See Remarks | F - Tax | $182.95 | -6,446 | 34.0K | -16% | -$1.18M |
| M | 2021-09-21 | 2021-09-20 | RVTY | Revvity | Mock James M | Please See Remarks | S - Sale | $184.87 | -6,080 | 23.3K | -21% | -$1.12M |
Purchase Sale Sale after option exercise All abbreviations